2. About Quay Pharma Provider of contract development and
manufacturing services to the pharmaceutical and healthcare
industries Based in the United Kingdom Founded in 2002 Global
client reach Privately owned, financially secure
3. Quay People Quay has 45 employees, with majority dedicated
to supporting customer projects Cross functional formulation
development, analytical and manufacturing team Flexibility
Responsiveness Dedicated project managers to deliver client
projects
4. Professor Mike Rubenstein (Founder and Chairman) Over 40
years experience in solid dosage form design, development and
manufacture Chemical engineer and pharmacist with QP status
Industrial background in R&D and production at GSK and AZ Prof.
of Pharmaceutical Technology and Director of the School of Pharmacy
and Chemistry at LJMU Author of five books and over 200 original
research papers in Pharmaceutical Technology in solid dosage
development and controlled drug delivery Professor John Collett
(Chief Scientific Officer) Professor of pharmaceutics at Manchester
University World authority on polymeric drug delivery with over 30
years formulation science experience Author of over 250 research
papers Specialist areas of expertise include; formulation of
solubilised systems development of modified release drug delivery
systems improving oral bioavailability of poorly water soluble
drugs
5. How we can help Solving complex drug development challenges
Overcoming challenging physiochemical properties of APIs Improving
performance of existing products Providing safe, robust products
for clinical trials Manufacturing services for wide range of dosage
forms Effective management of clients projects
6. Quay Services
7. Expertise with broad range of dosage forms tablets capsules
multiparticulates topicals oral liquids parenterals
8. Multi-faceted approach to solving solubility and
bioavailability challenges lipidic systems solid dispersions pH
control particle size reduction solubilising agents
9. Drug Delivery Expertise Controlled release tablets
Multi-particulate technologies Modified release microparticles
Semi-solids in capsules Coating technologies Permeation enhancing
technologies
10. Renowned Analytical Services Quay has excellent track
record in developing robust analytical methods for wide range of
compounds Method development and transfer Forced degradation
studies Formulation development support Stability studies QC
testing
11. Manufacturing Expertise GMP manufacture of broad range of
non-sterile dosage forms First in Man studies including XcelolabTM
Phase I/II clinical manufacturing Small scale Phase III
manufacturing Specials Manufacturing Potents / Cytotoxics
12. Reliable Supply of Products for Clinic or Market Bulk
packing of tablets or capsules Small scale blister packing
Individual patient packs Global distribution of clinical
supplies
13. Regulatory Status Manufacturers Authorisation for
Investigational Medicinal Products (IMPs) Specials manufacturing
licence Regular audits by clients and the UK regulatory authority
(MHRA) Registered as a manufacturing site with the FDA
14. CASE STUDY 1: Bioavailability Enhancement Using Lipidic
Systems CLIENT: UK Based Pharma Company THE BRIEF: Oncology
Treatment Poor aqueous solubility Bioavailability enhancement
needed to progress drug OUR SOLUTION: Solubility screening and
optimisation Two lipid based formulations developed Dog PK study
performed Dosage levels subsequently reduced Drug licensed to major
pharma
15. CASE STUDY 2: Flexible Targeted Delivery System CLIENT:
German Pharma Company THE BRIEF: New indication for existing
product 3 Phase delivery required Immediate release in stomach (IR)
Delayed release in small intestine (DR) Modified release in small
intestine (MR) Flexible dosing required OUR SOLUTION: Mini-tablet
system developed(